期刊文献+

温阳健脾汤加减治疗乙肝肝硬化顽固性腹水临床研究 被引量:8

Clinical Study of Wen-Yang Jian-Pi Decoction in Treatment of Hepatitis B Cirrhosis Patients with Refractory Ascites
下载PDF
导出
摘要 目的:观察温阳健脾汤治疗乙肝肝硬化顽固性腹水临床疗效。方法:选择我院乙肝肝硬化顽固性腹水患者81例,随机分治疗组41例和对照组40例,2组患者均给予抗病毒、保肝抗炎、利尿、补充白蛋白等常规治疗,治疗组再予温阳健脾汤,观察并记录2组患者治疗前后的自觉症状、腹围、尿量,肝功能主要指标及B超主要指标的变化。两组均给药1个月为1个疗程,疗程间休息3至5天,连续3个疗程后评定疗效。结果:治疗组总有效率为87.8%,对照组为70.0%,治疗组疗效明显优于对照组(P<0.05);并且治疗组在腹水、尿量、症状、体征及B超指标改善方面均优于对照组,且具有统计学意义(P<0.05)。结论:温阳健脾汤可有效治疗乙肝肝硬化顽固性腹水,为临床的应用提供理论基础。 This study was aimed to observe the clinical curative effect of Wen-Yang Jian-Pi(WYJP) decoction for treating hepatitis B cirrhosis patients with refractory ascites.A total of 81 hepatitis B cirrhosis patients with refractory ascites after admission to our hospital were randomly divided into two groups,41 patients were in the treatment group and40 were in the control group.Patients in both groups received basic treatment,including antivirus,liver-protective,antiinfective and diuretic therapy,as well as albumin supplementation;while the treatment group were additionally given oral traditional Chinese medicine(TCM) of WYJP decoction at the same time.Changes of subjective symptoms,abdominal circumference,urine volume,main hepatic function indexes,and main indexes of B-ultrasound before and after treatment were measured and compared between two groups.Patients in both groups were treated for 3 one-month therapeutic courses,with 3 to 5 day-intervals,after which the curative effect was evaluated.The results showed that the total effective rate in the treatment group was 87.8%,which was significant higher than that of 70.0% in the control group(P0.05).And the treatment group in ascites,urine volume,symptoms,body signs and B ultrasonic improvement were better than those of the control group,with statistical significance(P0.05).It was concluded that WYJP decoction has definite therapeutic effect on hepatitis B cirrhosis patients with refractory ascites.
机构地区 菏泽市中医医院
出处 《世界科学技术-中医药现代化》 CSCD 2017年第10期1666-1670,共5页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
关键词 乙肝肝硬化 顽固性腹水 利尿剂抵抗性腹水 脾肾阳虚 温阳健脾汤 临床研究 Hepatitis B cirrhosis, refractory ascites, diuretic-resistant ascites, spleen-kidney yang deficiency, Wen-Yang Jian-Pi decoction, clinical study
  • 相关文献

参考文献9

二级参考文献61

  • 1陈炎,陈亚蓓,陶荣芳.全腹腔穿刺放液对肝硬化门静脉血流动力学的影响[J].中国实用内科杂志,2004,24(8):473-475. 被引量:21
  • 2郝建宇,杨立新.肝硬化腹水病人的处理—美国肝病学会实践指南相关问答[J].中国实用内科杂志,2007,27(8):567-570. 被引量:51
  • 3Reynolds TB.Ascites[J].Clin Liver Dis,2000,4:151-168.
  • 4Rimola A,Garcia-Tsao G,Navasa M,et al.Diagnosis,treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document.International Ascites Club[J].Hepatology,2000,32:142-153.
  • 5Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club[J].Hepatology,2003,38:258-266.
  • 6Dudley F.Management of refractory ascites[J].J Gastroenterol,2004,19:194-199.
  • 7Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline,a kappa opioid agonist,in patients with cirrhosis[J].J Hepatol,2000,32:38-42.
  • 8Gerbes AL,Gulberg V,Gines P.Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist:a randomized double-blind multicenter trial[J].Gastroenterology,2003,124(4):933-939.
  • 9Vila MC,Coll S,Sola R,et al.Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia[J].Am J Gastroenterol,1999,94:2219-2223.
  • 10Sola-Vera J,Minana J,Ricart E,et al.Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites[J].Hepatology,2003,37(5):1147-1153.

共引文献14086

同被引文献113

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部